Related Articles
Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review)
BTG2 as a tumor target for the treatment of luminal A breast cancer
Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray
21‑Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes
Stem cell targeted therapeutic approaches for molecular subtypes of clinical breast cancer (Review)